In recent years, there are more studies trying to integrate CEA into both preoperative diagnosis and postoperative follow-up of patients with medullary thyroid carcinoma, particularly in combination with the measurement of calcitonin, to define its prognosis. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.